Ameritas Investment Company’s Takeda Pharmaceutical TAK Stock Holding History

Ameritas Investment Company’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-413	Closed	-$7.54K	–	1925
2021 Q1	$7.54K	Buy	+413	New	+$7.43K	﹤0.01%	1609
2020 Q2	–	Sell	-231	Closed	-$4K	–	1460
2020 Q1	$4K	Hold	231	–	–	﹤0.01%	1460
2019 Q4	$5K	Sell	231 -18	-7%	-$344	﹤0.01%	793
2019 Q3	$4K	Buy	+249	New	+$4.31K	﹤0.01%	1336
2019 Q2	–	Sell	-21	Closed	–	–	806
2019 Q1	$0	Buy	+21	New	+$423	﹤0.01%	1700

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameritas Investment Company's TAK Position: Q2 2021 in Review

Ameritas Investment Company sold out of Takeda Pharmaceutical (TAK) in Q2 2021, closing a stake of 413 shares — an estimated $7.54K sold.

Ameritas Investment Company first reported a position in TAK in Q1 2019 and held it in 5 quarters. The position peaked at $7.54K in Q1 2021. 305 funds tracked by Wall St. Rank hold TAK as of Q2 2021.

Ameritas Investment Company reported no remaining Takeda Pharmaceutical position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Company sold 413 Takeda Pharmaceutical shares in Q2 2021, an estimated $7.54K.
Ameritas Investment Company first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 5 quarters.
Ameritas Investment Company's Takeda Pharmaceutical position peaked at $7.54K in Q1 2021.
305 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.